HologicFRA:HO1 57 FCF Yield % is 5.64 as of Jun. 28, 2026, which is 5% above its 10-year median of 5.38. GuruFocus rates FRA:HO1 with a GF Score™ of 57/100 and a GF Value™ of €70.17. The stock has 4 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Hologic ranks better than 84.56% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Hologic's Trailing 12-Month Free Cash Flow is €830 Mil, and Market Cap is €14,704 Mil. Therefore, Hologic's FCF Yield % for today is 5.64%.
The historical rank and industry rank for Hologic's FCF Yield % or its related term are showing as below:
FRA:HO1'
s FCF Yield % Range Over the Past 10 Years
Min: -0.96 Med: 5.38 Max: 15.09
Current: 5.64
During the past 13 years, the highest FCF Yield % of Hologic was 15.09%. The lowest was -0.96%. And the median was 5.38%.
FRA:HO1's FCF Yield % is ranked better than 84.56% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.38
vs FRA:HO1: 5.64
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Hologic FCF Yield % Related Terms
Hologic FCF Yield % Historical Data
* Premium members only.
The historical data trend for Hologic's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Hologic's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hologic FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hologic's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Hologic's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hologic (FRA:HO1) has a FCF Yield % of 5.64 as of Jun. 28, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Hologic and its competitors. This is near median its historical median of 5.38. According to the industry distribution chart, Hologic ranks #132 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 15.4%.
Is Hologic's FCF Yield % too high?
Hologic's current FCF Yield % of 5.64 is near median its 10-year median of 5.38. Based on the distribution chart, Hologic ranks #132 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Hologic has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Hologic's FCF Yield % compare to WST and COO?
According to the Medical Devices & Instruments industry distribution chart, Hologic ranks #132 out of 855 companies for FCF Yield %. This places Hologic in the top 15% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Hologic and its competitors. Hologic's current FCF Yield % is 5.64, which is near median its own 10-year median of 5.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hologic stock overvalued right now?
Hologic (FRA:HO1) has a current FCF Yield % of 5.64. The stock's GF Value™ is €70.17, compared to a current price of €65.00 — trading 7.4% below its estimated fair value. The current FCF Yield % is 5.64, which is near median its 10-year median of 5.38. Hologic's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Hologic (FRA:HO1), the current FCF Yield % is 5.64 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hologic (FRA:HO1) Overvalued in 2026?
Based on GuruFocus' analysis, Hologic stock appears to be undervalued.
The current stock price of €65.00 is trading 7.4% below its estimated GF Value™ of €70.17.
Key valuation signals for FRA:HO1:
FCF Yield %: 5.64 (near median its 10-year median of 5.38)
GF Value™: €70.17 vs. price of €65.00 (7.4% below fair value)
No single metric tells the full story. See the FRA:HO1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
57GF Score
Get the complete analysis for FRA:HO1
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HO1 has been successfully added to your 
